We serve Chemical Name:2-Oxa-5-azaspiro[3.5]nonane-6,8-dione CAS:1105665-49-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
![2-Oxa-5-azaspiro[3.5]nonane-6,8-dione](https://a.dearchem.com/CAS2/1105665-49-3.png)
Chemical Name:2-Oxa-5-azaspiro[3.5]nonane-6,8-dione
CAS.NO:1105665-49-3
Synonyms:2-Oxa-5-azaspiro[3.5]nonane-6,8-dione
Molecular Formula:C7H9NO3
Molecular Weight:155.15100
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:58.89000
Exact Mass:155.05800
LogP:
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-Oxa-5-azaspiro[3.5]nonane-6,8-dione chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Oxa-5-azaspiro[3.5]nonane-6,8-dione physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Oxa-5-azaspiro[3.5]nonane-6,8-dione Use and application,2-Oxa-5-azaspiro[3.5]nonane-6,8-dione technical grade,usp/ep/jp grade.
Related News: The program caused the price of some drugs to plunge more than 90% when it was introduced last year in some cities, state news agency Xinhua said. 2-Oxa-5-azaspiro[3.5]nonane-6,8-dione manufacturer Corden Pharma group companies offer contract development and contract manufacturing for advanced pharmaceutical intermediates, APIs, and drug product formulations with more than 1,500 individuals supporting their customers with specialized technologies in all international markets. 2-Oxa-5-azaspiro[3.5]nonane-6,8-dione supplier A Phase 1/2 trial of the combination therapy has been fully enrolled, and the preliminary efficacy and safety data was presented at The American Society of Hematology (ASH) Annual Meeting in December 2018. 2-Oxa-5-azaspiro[3.5]nonane-6,8-dione vendor Of the nearly 4,000 Black women and more than 25,000 white women included in the study, there was no statistically significant difference in breast cancer-related genetic mutations. They were found in 5.65% of Black women and nearly 5.1% of white women. 2-Oxa-5-azaspiro[3.5]nonane-6,8-dione factory Corden Pharma group companies offer contract development and contract manufacturing for advanced pharmaceutical intermediates, APIs, and drug product formulations with more than 1,500 individuals supporting their customers with specialized technologies in all international markets.
